top of page

YOUR INTRAVASCULAR EYES

Forward-looking, real-time, full-color intravascular imaging at 1 millimeter. 

VerAvanti is developing forward-viewing imaging catheters about one millimeter in diameter. Our first product, Luce, is a single-use catheter and console designed to show the interventionalist, live and in color, what lies directly ahead of the catheter. Our Scanning Fiber Endoscope (SFE) platform, licensed exclusively from the University of Washington, is designed to add further imaging modalities at the same small size. 

Nearly one million people are diagnosed with heart disease each year, with approximately 200,000 suffering from Chronic Total Occlusions (CTOs). This condition, which affects many catheterization patients, remains one of the most challenging issues in cardiology. Current success rates for intervention hover around just 55%, leaving the majority of patients without effective treatment. Limitations in existing imaging technology hinder doctors from accurately diagnosing and treating these life-threatening blockages, creating a critical gap in patient care.

Current imaging Technology is hindering treatment

Current imaging Technology is hindering treatment

LongGradient.webp

Heart Disease and Diagnostic Demand

Over 20 million people are living with heart disease, of which 1 million have heart attacks each year. These numbers highlight a critical need for improved diagnostic solutions.

LongGradient.webp

Ischemic Stroke Prevalence

About 795,000 people in the United States have a stroke each year (American Heart Association). In roughly one in four ischemic strokes, no cause is found.

LongGradient.webp

Stroke Diagnostics and Causes

25% of embolic stroke patients live without knowing where the emboli originated. These patients often have recurring strokes.

LongGradient.webp

Lung Cancer and the Diagnostic Gap

Lung cancer is the leading cause of cancer death in the EU, with 380,000 deaths each year. Ultra-peripheral nodules — the most critical to catch early — carry a 28–35% false-negative biopsy rate with current tools, leaving a significant portion of early-stage cases undetected.

LongGradient.webp

The Terminal Bronchiole Barrier

Today's bronchoscopes cannot reach most of the smallest airways, which are under one millimeter across. The inability to navigate to this anatomy is a direct barrier to better outcomes.

Gradient.webp

Optical Coherence Tomography (OCT)

Gradient.webp

IntraVascular UltraSound (IVUS)

What today's imaging cannot show

Current imaging technologies like Angiography, IVUS, and OCT are inflexible and invasive, complicating procedures and increasing infection risks.

✗ Angiography shows a contrast shadow and cannot show a segment that contrast does not fill.

✗ IVUS and OCT image the vessel wall beside the catheter, not the lesion face ahead of it.

Forward-viewing imaging at one millimeter is the gap VerAvanti is working to close.

What VerAvanti is designed to do

VerAvanti's Scanning Fiber Endoscope (SFE) is designed to bring forward-looking, high-resolution imaging to minimally invasive vascular procedures. Unlike side-view methods, it is intended to deliver real-time, full-color visuals deep in arteries, giving clinicians a clearer view of plaques and vessel wall features.

✔ Forward-Looking Imaging: Our SFE enables clinicians to see directly ahead, overcoming traditional side-view limitations.

✔ Real-Time Clarity: High-resolution visuals reveal crucial anatomical details instantly for precise diagnosis and treatment.

✔ Full-Color Visualization: Full color endoscopic video imaging from a 1mm diameter device that has access to small vessels and other small body spaces.

Disclaimer: The product shown in this video represents prototype hardware and is subject to change. Final specifications, features, and appearance may vary.

Our Potential Impact Points

We're Advancing intravascular Imaging

At the heart of VerAvanti’s Scanning Fiber Endoscope (SFE) is a piezo-actuated optical fiber that scans RGB laser light in a resonant spiral pattern. The device directs this scan from its distal tip, while reflected signals are captured through surrounding collection fibers and reconstructed into real-time, full-color video.
 

This laser-based angioscopy approach is designed to provide real-time and forward-looking intravascular visualization, addressing structural limitations of angiography, IVUS, and OCT. As an investigational technology, the SFE is being developed to complement existing imaging modalities and advance diagnostic precision and treatment decision-making in complex vascular disease.

LongGradient.webp

Real-time visual feedback

Designed to give clinicians a live view of what lies ahead of the catheter, to support decisions during the procedure.

LongGradient.webp

Single-use design

Designed for single use, so there is no reprocessing between patients.

LongGradient.webp

Procedure workflow

Designed to fit existing cath lab workflow. Effects on procedure time will be measured in clinical studies.

LongGradient.webp

Diagnostic information

Designed to add direct visual information to what angiography, IVUS and OCT already provide.

Our Technological Innovations

Real-Time Visual Feedback

Delivers high-resolution, live imaging to help clinicians see precise details instantly. This could reduce errors and improve decision-making for possible better patient outcomes.

Single-Use Design

Built for single-use aiming to improve sterility and eliminate cross-contamination risks. This design goal will be to improve on overall sterilization, potentially increasing patient safety and workflow efficiency.

Fiber Optic Technology

Utilizes a compact fiber-optic cable for sharp, detailed images in hard-to-reach areas. Enhanced visuals show potential to support more accurate diagnoses and targeted treatments.

Minimal Invasiveness

Fits seamlessly into procedures with minimal entry points, with the goal of reducing trauma and recovery time so patients could experience safer, faster recoveries, and hospitals increase treatment capacity.

Senso software

Senso is AI-enabled software in development for the VerAvanti console, designed to help the operator interpret what the catheter shows. It is a tool for the interventionalist, not a substitute for clinical judgment."
And change "Minimal Invasiveness" to: "About one millimeter in diameter, designed to reach small vessels through standard access.

05

Our Technological Innovations

Real-Time Visual Feedback

Delivers high-resolution, live imaging to help clinicians see precise details instantly. This reduces errors and improves decision-making for better patient outcomes.

Single-Use, Sterile Design

Built for single-use to ensure sterility and eliminate cross-contamination risks. This design saves time on sterilization, increasing patient safety and workflow efficiency.

Fiber Optic Technology

Utilizes a compact fiber-optic cable for sharp, detailed images in hard-to-reach areas. Enhanced visuals support accurate diagnoses and targeted treatments.

Minimal Invasiveness

Fits seamlessly into procedures with minimal entry points, reducing trauma and recovery time. Patients experience safer, faster recoveries, and hospitals increase treatment capacity.

Intelligent Image

Incorporates smart image interpretation to guide clinicians with enhanced clarity during procedures. This streamlines complex tasks, allowing for improved patient care.

Clinical Perspectives

SavastanoL_Updated_Headshot.jpg

Dr. Luis Savastano

UCSF Co-Chief of NeuroEndovascular Surgery
Medical Director, Cerebrovascular Neurosurgery

“In complex vascular procedures, key decisions often depend on understanding structures that are not directly visible with current imaging approaches. Improving visualization of what lies ahead of the catheter remains an important unmet need in both coronary and neurovascular interventions.”

cff9f026.jpg

Dr. Lorenzo Azzalini

MD, PhD, MSc, FACC, FSCAI
UW Medicine

“The SFE is going to captivate people. It offers a very different way of visualizing the vessel compared to what we’re used to today. In complex PCI, we’re used to integrating information from different imaging sources, and having a more direct view of what’s ahead could be very helpful in guiding decision-making.” 

Explore Our Featured Milestones

VerAvanti Named Finalist for Innovation of the Year at the 2026 GeekWire Awards

VerAvanti

Mar 18, 2026

Middle East Family Office Invests $5 Million in VerAvanti, Securing Exclusive Regional Distribution Rights for SFE Technology

VerAvanti

Oct 20, 2025

VerAvanti Announces $31.5 Million Series A Close, Manufacturing Expansion, and Key Research Collaboration

VerAvanti

May 13, 2025

VerAvanti Secures $28 Million in First Tranche of Series A funding to Advance Intravascular Imaging Technology

VerAvanti

Mar 11, 2025

VerAvanti is growing - Expands Executive Team

VerAvanti

Dec 9, 2024

Contact Us

Interested In Learning More or Exploring Partnerships?

Region
What type of partnership or information are you interested in
bottom of page